CIK 0001453687
- Non-accelerated filer
- Smaller reporting company
Cartesian Therapeutics, Inc.
Sign in to watch- Ticker
- RNAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 301-348-8698
- Business address
- 7495 NEW HORIZON WAY, FREDERICK, MD, 21703
- Former names
- SELECTA BIOSCIENCES INC
- 4 Open-market sale Chief Scientific Officer sold 3,892 shares at $4.39 ($17,086)
- 4 Open-market sale Chief Operations Officer sold 3,892 shares at $4.39 ($17,086)
- 4 Open-market sale President and CEO sold 15,313 shares at $4.39 ($67,224)
- 4 Grant or award Chief Medical Officer acquired 13,750 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 13,750 shares (grant or award)
- 4 Grant or award Chief Operations Officer acquired 13,750 shares (grant or award)
- 4 Grant or award President and CEO acquired 37,500 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 9,100 shares (grant or award)
- 4 Grant or award President and CEO acquired 27,200 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale President and CEO sold 4,523 shares at $4.51 ($20,399)
- 4 Open-market buy Director bought 9,000 shares at $4.00 ($36,000)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale President and CEO sold 4,806 shares at $4.38 ($21,041)
- 4 Open-market buy Chief Medical Officer bought 20,000 shares at $3.99 ($79,850)
- 4 Open-market buy Director bought 1,900,000 shares at an average $3.72 ($7,059,872)
- 4 Open-market buy Chief Medical Officer bought 17,500 shares at an average $3.37 ($58,898)
Page 10 of 21 · 410 filings